GlassScriptPhysician profile
Ronald C Huffman
NPI 1730182957
$1,100.20
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $689 · 2020: $411.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $176.59 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $95.69 | 2019-2020 | |
| Novo Nordisk INC | $79.64 | 2019-2020 | |
| Amgen INC. | $71.12 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $68.36 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.87 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.96 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.16 | 2019 | |
| Allergan, INC. | $41.98 | 2019-2020 | |
| Adlon Therapeutics L.P. | $41.48 | 2019-2020 | |
| Neos Therapeutics, LP | $38.54 | 2019-2020 | |
| Glaxosmithkline, LLC. | $34.45 | 2019 | |
| Shire North American Group INC | $34.35 | 2019 | |
| Ironwood Pharmaceuticals, INC | $28.62 | 2019-2020 | |
| Seqirus USA INC | $27.91 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $26.84 | 2019-2020 | |
| Lilly USA, LLC | $26.22 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $24.38 | 2019 | |
| Masimo Corporation | $24.33 | 2019 | |
| Genentech USA, INC. | $15.50 | 2020 | |
| Sanofi Pasteur INC. | $15.23 | 2020 | |
| Tris Pharma INC | $14.37 | 2020 | |
| Eisai INC. | $11.28 | 2020 | |
| Amarin Pharma, INC. | $11.24 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Huffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.